Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10946018 Spirocyclic compounds as tryptophan hydroxylase inhibitors

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Kenneth Brameld0

Stéphane De Lombaert0

Andrew Scribner0

Daniel R. Goldberg0

Eric Brian Sjogren0

Date of Patent

March 16, 2021

0

Patent Application Number

168505420

Date Filed

April 16, 2020

0

Patent Citations

US Patent 10350208 Spirocyclic compounds as tryptophan hydroxylase inhibitors

US Patent 10045988 Spirocyclic compounds as tryptophan hydroxylase inhibitors

Patent Citations Received

US Patent 11576915 Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension and daily dosing

US Patent 11607413 Dosage regime and method for treating pulmonary arterial hypertension

0

US Patent 11759462 Spirocyclic compounds as tryptophan hydroxylase inhibitors

US Patent 11413287 Method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension

Patent Primary Examiner

0

Patent abstract

The present invention is directed to spirocyclic compounds which are inhibitors of tryptophan hydroxylase (TPH), particularly isoform 1 (TPH1), that are useful in the treatment of diseases or disorders associated with peripheral serotonin including, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, and low bone mass diseases, as well as serotonin syndrome, and cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10946018 Spirocyclic compounds as tryptophan hydroxylase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool